scholarly journals Medical Nutrition Therapy in Type 2 Diabetes Mellitus

2019 ◽  
Vol 5 (10) ◽  
pp. 77-83
Author(s):  
A. Evseev

The article deals with the problems of diabetes mellitus sickness rate which are considered vital today. These problems are determined by the increase in the diabetes sickness rate across Russia and the world, as well as its medical and social consequences. Special attention is paid to the risk factors of diabetes mellitus. The author makes research into the pathogenesis of the type 2 diabetes mellitus and a number of approaches to its outpatient treatment. The article analyses modern sources in clinical nutrition of type 2 diabetes; accumulates practical experience published in foreign-based medical books. The author made an attempt to characterize the system of diets used in type 2 diabetes therapy. The article can be useful for doctors of the relevant field.

2009 ◽  
Vol 35 (6) ◽  
pp. 1004-1013 ◽  
Author(s):  
Otilia Perichart-Perera ◽  
Margie Balas-Nakash ◽  
Adalberto Parra-Covarrubias ◽  
Ameyalli Rodriguez-Cano ◽  
Aurora Ramirez-Torres ◽  
...  

2021 ◽  
Vol 11 (4) ◽  
pp. 850-859
Author(s):  
Sanjay Kalra ◽  
Ganapathi Bantwal ◽  
Nitin Kapoor ◽  
Rakesh Sahay ◽  
Saptarshi Bhattacharya ◽  
...  

Type 2 diabetes mellitus (T2DM) is a chronic progressive disorder and is associated with significant morbidity and mortality. The concept of T2DM remission and the reversal of diabetic parameters to normal levels has been gaining momentum over the past years. T2DM remission is increasingly being recognized by various global guidelines. Multiple models have been developed and validated for quantifying the extent of remission achieved. Based on favorable clinical evidence, T2DM remission can be considered as the therapeutic goal in diabetes management and, in select cases, as an alternative to expensive treatment options, which can be burdensome as T2DM progresses. This narrative review discusses the available strategies, such as lifestyle interventions, physical activity, bariatric surgery, medical nutrition therapy, and non-insulin glucose-lowering medications, for achieving T2DM remission. Although the concept of T2DM remission has emerged as a real-world option, effective implementation in routine clinical practice may not be feasible until long-term studies prove the efficacy of different approaches in this regard.


2019 ◽  
Vol 36 (3) ◽  
pp. 520-547 ◽  
Author(s):  
Vijay Viswanathan ◽  
Dharini Krishnan ◽  
Sanjay Kalra ◽  
Rajeev Chawla ◽  
Mangesh Tiwaskar ◽  
...  

2005 ◽  
Vol 31 (5) ◽  
pp. 719-725 ◽  
Author(s):  
Pamela Galasso ◽  
Allison Amend ◽  
Gail D. Melkus ◽  
Genice T. Nelson

Purpose The purpose of this study was to explore food purchasing, preparation, and consumption among black women with type 2 diabetes mellitus (T2DM) in an urban setting to assess barriers to medical nutrition therapy recommendations. Methods A telephone survey was developed to assess shopping habits, the use of community resources for food supplementation, use of restaurant/fast-food establishments, dining habits, food purchasing and consumption, and food preparation methods. This 38-item questionnaire provided both frequencies and trends regarding participants’ dietary habits. Results Black women identified ways in which their participation in a culturally competent intervention of diabetes care and education helped them to change dietary behaviors. The most common areas of change included purchasing, preparation, and portion size. Barriers to medical nutrition therapy identified included low income, time constraints, competing demands, and knowledge deficits. Conclusions Culturally sensitive diabetes interventions are an effective way to overcome some of the barriers to medical nutrition therapy. Feedback provided by this survey suggests that identification of more affordable healthy food resources in the community is necessary. In addition, access issues such as transportation to grocery stores should be on the agenda for public policy issues. Finally, alternate sites for nutrition education, such as a supermarket forum, warrant further investigation.


2021 ◽  
Vol 1 (29) ◽  
pp. 8-12
Author(s):  
D. Yu. Sedykh ◽  
V. V. Kashtalap ◽  
O. L. Barbarash

The article demonstrates the practical experience of the effective use of inhibitor of sodium-glucose co-transporter 2 emplagliflozin as a part of optimal drug therapy in patients with decompensation of chronic heart failure with systolic dysfunction of ischemic genesis and type 2 diabetes mellitus. The place of this group of drugs in improving the quality of life and prognosis in patients with severe comorbidity has been indicated according to the data of evidence-based studies.


Sign in / Sign up

Export Citation Format

Share Document